GRAIL, LLC (GRAL)
$20.46 $0.22 (1.07%) 4:38 PM 12/11/24
NASDAQ | $USD | Diagnostics & ResearchStock Data
-
Market Cap
$726.45M -
Day's Range
$20.60 - $21.98 -
Volume
938,330 -
52 Week Low / High
$12.33 - $23.44 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
GRAL's Dividend
Analyists Ranking
- 0
- Strong Buy
- 0
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong Sell
- $0.00
- Target Price
Company News
-
Results of GRAIL's Galleri® Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology — Aug 29th, 2024
Data Support Clinical Performance of Galleri to Detect More Aggressive Prostate Cancers MENLO PARK, Calif., Aug. 29, 2024 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL) a healthcare company whose mission is to detect cancer early when it can be cured, today announced that detailed findings of...
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$